Eton Pharmaceuticals, Inc. (ETON) insider buying and selling

NASDAQ: ETON · Source: SEC Form 4 filings · Latest trade reported

In the last 90 days at Eton Pharmaceuticals, Inc. (ETON), no insider made an open-market purchase and 3 insiders made 8 open-market sales worth $10.7M, as reported on SEC Form 4. Over the last 12 months, 4 insiders sold $19.3M.

Insider buys, 90 days
0
$0 · 0 insiders
Insider sales, 90 days
8
$10.7M · 3 insiders
Insider buys, 12 months
0
$0 · 0 insiders
Insider sales, 12 months
16
$19.3M · 4 insiders

This is the public summary. Create a free account to see ETON’s AI Signal, the price chart with every insider trade plotted, and each insider’s track record.

Unlock ETON

Recent open-market insider trades

Trades by the same insider within a week are shown as one line.

Open-market insider trades at Eton Pharmaceuticals, Inc.
DateInsiderTypeSharesPriceValue
PAUL MAIER V
Director
Open market sale
3 trades
50,000avg. $59.07$3.0M
David Krempa
Chief Business Officer
Open market sale25,000$65.07$1.6M
SEAN BRYNJELSEN
CEO
Open market sale
4 trades
100,000avg. $60.88$6.1M
Jennifer McKie Adams
Director
Open market sale50,000$32.48$1.6M
SEAN BRYNJELSEN
CEO
Open market sale
2 trades
120,000avg. $31.88$3.8M
David Krempa
Chief Business Officer
Open market sale
5 trades
100,000avg. $32.30$3.2M

What the ETON insider trades really mean

The table above is the public summary. With an Insider Intel account you get the analysis behind it, for Eton Pharmaceuticals, Inc. and every other stock we track:

The AI Signal weighs:Insider buyingAnalyst ratingPrice upsideAI OutlookInsider track recordBreakout pressure

Plus AI summaries, the latest news for each stock, and an AI assistant you can ask questions about any of it.

Get started free with ETON Insider Intel tracks insider activity at 3,154 companies right now. The Free plan includes full price charts and trade history, watchlists and email alerts.

Questions about ETON insider trading

Who bought Eton Pharmaceuticals, Inc. (ETON) stock recently?

No insider made an open-market purchase of Eton Pharmaceuticals, Inc. (ETON) stock in the last 12 months.

Are insiders buying or selling ETON?

Over the last 12 months insiders were net sellers of ETON on discretionary trades: $0 bought against $19.3M sold (scheduled and tax-related sales excluded).

What is a sell-to-cover or 10b5-1 sale?

A 10b5-1 sale is scheduled in advance under a pre-arranged plan, and a sell-to-cover sale is made to pay tax on vesting shares. Neither is a fresh decision to sell, so they say less about an insider's view than a discretionary sale.

Where does this data come from?

Officers, directors and large shareholders report their trades to the SEC on Form 4. This page lists the open-market purchases and sales by individual insiders from those public filings; funds and other institutions are not shown.

Other stocks with recent insider buying

Ready to see ETON in full?

Create a free account and open its chart, score and alerts.

Create your free account

How to read this page

Officers, directors and large shareholders must report their trades in company shares to the SEC on Form 4. This page lists open-market purchases and sales by individual insiders: trades made on the stock exchange at the going price. Funds and other institutions are not shown here.

Information from SEC EDGAR Form 4 filings, shown for general information only. It is not financial advice and does not recommend buying or selling any security. Trades are shown by transaction date and may be reported up to two business days later.